AUG 10, 2026 · PHASE 4 TRIAL
Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors
ClinicalTrials.gov
This is a Phase 4 interventional study registration with no results posted; it describes planned pharmacokinetic endpoints in a small estimated cohort and cannot support clinical efficacy or safety conclusions.
Reported
Estimated enrollment12
Primary outcome measure 1Area Under the Plasma Concentration-Time Cu…
Primary outcome measure 2Area under the plasma concentration-time cu…